Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic, Hematopoietic Cell Transplant (HCT)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 0 results

Testing effectiveness (Phase 2)Enrolling By InvitationNCT02646839
What this trial is testing

KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndromes
Michael Pulsipher 50
Testing effectiveness (Phase 2)Study completedNCT01809847
What this trial is testing

Ofatumumab Induction and Maintenance in Elderly Patients With Poor Risk CLL in the Context of Allogeneic Transplantation

Who this might be right for
Chronic Lymphatic Leukemia
Technische Universität Dresden 20
Testing effectiveness (Phase 2)Study completedNCT01772953
What this trial is testing

Treosulfan/Fludarabine/Low Dose TBI as a Preparative Regimen for Children With AML/MDS Undergoing Allo HCT

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)
Center for International Blood and Marrow Transplant Research 40
Testing effectiveness (Phase 2)WithdrawnNCT05604742
What this trial is testing

Belimumab for Treatment of cGVHD Following Allo-HCT

Who this might be right for
cGVHD
xuna
Not applicableStudy completedNCT00360685
What this trial is testing

Tacrolimus and Mycophenolate Mofetil (MMF) in GVHD Prophylactic Regimen Compared to Tacrolimus and Methotrexate (MTX

Who this might be right for
MucositisGraft-versus-host Disease
H. Lee Moffitt Cancer Center and Research Institute 89
Testing effectiveness (Phase 2)Study completedNCT00504803
What this trial is testing

Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host Disease

Who this might be right for
Hematological Malignancies
University of Liege 30
Not applicableStudy completedNCT02077218
What this trial is testing

Computed Tomography and Biomarker Analysis in Diagnosing Coronary Artery Disease in Asymptomatic Patients Who Have Undergone Stem Cell Transplant

Who this might be right for
Cancer SurvivorDiabetes MellitusHypertension
City of Hope Medical Center 20
Not applicableStudy completedNCT03910478
What this trial is testing

Dried Blood Spot Testing of CMV Detection in HCT Recipients

Who this might be right for
Cytomegalovirus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 622
Testing effectiveness (Phase 2)Looking for participantsNCT05736419
What this trial is testing

Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)

Who this might be right for
Sickle Cell DiseaseThalassemia, BetaThalassemia
Memorial Sloan Kettering Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT04151706
What this trial is testing

CD34 Selected Allogeneic HCT w/ Myeloablative Conditioning Plus CD8+ Memory TCell Infusion in MDS, AL and CML

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndromes+2 more
Robert Lowsky 7
Large-scale testing (Phase 3)Study completedNCT01877655
What this trial is testing

Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT)

Who this might be right for
Cytomegalovirus (CMV)-Positive RecipientsAllogeneic, Hematopoietic Cell Transplant (HCT)
Astellas Pharma Global Development, Inc. 514
Testing effectiveness (Phase 2)Active Not RecruitingNCT05683457
What this trial is testing

Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Allogenic Hematopoietic Cell Transplantation (HCT) Participants.

Who this might be right for
Cytomegalovirus Infection
ModernaTX, Inc. 84
Not applicableActive Not RecruitingNCT06679530
What this trial is testing

Music During Allogeneic Stem Cell Transplant Hospitalization

Who this might be right for
Hematopoietic Cell Transplantation (HCT)
University of Colorado, Denver 35
Testing effectiveness (Phase 2)Ended earlyNCT04582864
What this trial is testing

Flotetuzumab for Relapsed Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Following Allogeneic Hematopoietic Cell Transplantation (Allo-HCT)

Who this might be right for
Relapsed Acute Myeloid Leukemia
Washington University School of Medicine 11
Early research (Phase 1)Study completedNCT04139577
What this trial is testing

FMT In High-Risk Acute GVHD After ALLO HCT

Who this might be right for
Acute Graft-Versus-Host Disease (Gvhd) GradeHematopoietic Cell TransplantationFecal Microbiota Transplant
Massachusetts General Hospital 10
Not applicableStudy completedNCT03200977
What this trial is testing

Safety of Allogeneic Hematopoietic Cell Transplantation (HCT) For Patients With Classical Hodgkin Lymphoma (CHL) Treated With Nivolumab

Who this might be right for
Lymphoma
Bristol-Myers Squibb 95
Early research (Phase 1)Ended earlyNCT06158100
What this trial is testing

Venetoclax in Combination With Azacitidine (VEN/AZA) Followed by Donor Lymphocyte Infusion (DLI) for Patients With Very High-Risk Acute Myeloid Leukemia (AML) Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)

Who this might be right for
Acute Myeloid Leukemia
Antonio M Jimenez Jimenez 2
Testing effectiveness (Phase 2)Looking for participantsNCT06508099
What this trial is testing

Vitamin A and D Supplementation in Allogeneic HCT

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaBiphenotypic Acute Leukemia+5 more
St. Petersburg State Pavlov Medical University 220